Duloxetine sprinkles

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9839626
SERIAL NO

15486670

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates in part a to multiparticulate sprinkle dosage form comprising duloxetine or a pharmaceutically acceptable salt thereof, having higher acid resistance as compared to commercially available delayed release formulations. It further relates to various methods of administering the said multiparticulate sprinkle dosage forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SUN PHARMACEUTICAL INDUSTRIES LIMITEDSUN HOUSE PLOT NO 201 B/1 WESTERN EXPRESS HIGHWAY GOREGAON (E) MUMBAI MAHARASHTRA 400063 400063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Agarwal, Ravindra Udaipur, IN 12 10
Kochhar, Ravi Gurgaon, IN 22 25
Singhal, Tarun Bharatpur, IN 16 89

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00